Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
Total Valuation
Neurocrine has a market cap or net worth of $15.43B. The enterprise value is $13.75B.
Market Cap$15.43B
Enterprise Value$13.75B
Share Statistics
Neurocrine has 99,705,696 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding99,705,696
Owned by Insiders1.10%
Owned by Institutions0.90%
Financial Efficiency
Neurocrine’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 12.48%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)12.48%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee1.31M
Profits Per Employee189.61K
Employee Count1,800
Asset Turnover0.63
Inventory Turnover0.59
Valuation Ratios
The current PE Ratio of Neurocrine is 36.4. Neurocrine’s PEG ratio is 1.22.
PE Ratio36.4
PS Ratio5.82
PB Ratio5.29
Price to Fair Value5.29
Price to FCF24.60
Price to Operating Cash Flow22.35
PEG Ratio1.22
Income Statement
In the last 12 months, Neurocrine had revenue of 2.36B and earned 341.30M in profits. Earnings per share was 3.40.
Revenue2.36B
Gross Profit2.32B
Operating Income570.50M
Pretax Income486.00M
Net Income341.30M
EBITDA639.70M
Earnings Per Share (EPS)3.40
Cash Flow
In the last 12 months, operating cash flow was 636.80M and capital expenditures -43.70M, giving a free cash flow of 593.10M billion.
Operating Cash Flow636.80M
Free Cash Flow593.10M
Free Cash Flow per Share5.95
Dividends & Yields
Neurocrine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change19.82%
50-Day Moving Average142.02
200-Day Moving Average126.84
Relative Strength Index (RSI)62.99
Average Volume (3m)997.26K
Important Dates
Neurocrine upcoming earnings date is Feb 11, 2026, After Close (Confirmed).
Last Earnings DateOct 28, 2025
Next Earnings DateFeb 11, 2026
Ex-Dividend Date―
Financial Position
Neurocrine as a current ratio of 3.40, with Debt / Equity ratio of 14.26%
Current Ratio3.40
Quick Ratio3.28
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio4.51
Taxes
In the past 12 months, Neurocrine has paid 144.70M in taxes.
Income Tax144.70M
Effective Tax Rate0.30
Enterprise Valuation
Neurocrine EV to EBITDA ratio is 21.77, with an EV/FCF ratio of 24.99.
EV to Sales5.91
EV to EBITDA21.77
EV to Free Cash Flow24.99
EV to Operating Cash Flow23.39
Balance Sheet
Neurocrine has $1.11B in cash and marketable securities with $428.40M in debt, giving a net cash position of $686.40M billion.
Cash & Marketable Securities$1.11B
Total Debt$428.40M
Net Cash$686.40M
Net Cash Per Share$6.88
Tangible Book Value Per Share$25.37
Margins
Gross margin is 98.37%, with operating margin of 24.22%, and net profit margin of 14.49%.
Gross Margin98.37%
Operating Margin24.22%
Pretax Margin20.63%
Net Profit Margin14.49%
EBITDA Margin27.16%
EBIT Margin26.01%
Analyst Forecast
The average price target for Neurocrine is $176.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$176.67
Price Target Upside15.95% Upside
Analyst ConsensusStrong Buy
Analyst Count23
Revenue Growth Forecast19.61%
EPS Growth Forecast11.36%